drug

zeleciment basivarsen

1 story · latest Sep 29, 2026

Status: Investigational
Code: DYNE-101
Trials: 2 registered trials in coverage

Relationships

Developed by Dyne Therapeutics

Timeline

Dyne reports new one-year data from ACHIEVE trial of z-basivarsen in DM1

Sep 29Clinical readoutDyne Therapeutics

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.